Evidence map›Paper›PMID 35953432›Full record

ArticleTrends in endocrinology and metabolism: TEM2022

Location matters: hexokinase 1 in glucose metabolism and inflammation.

Sivaraj M Sundaram, Luke A Doughty, Michael W Sereda

Abstract readComment
PubMed Publisher
In one paragraph

Article in Trends in endocrinology and metabolism: TEM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Total-Body Multiparametric PET Quantification ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  5. Total-Body Multiparametric PET Quantification ofmedRxiv : the preprint server for health sciences · 2023
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sivaraj M SundaramDepartment of Neurology, University Medical Center Goettingen, Goettingen, Germany; Research Group Translational Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Goettingen, Germany. Electronic address: mohana.sivaraj@mpinat.mpg.de.
Luke A DoughtyDepartment of Neurology, University Medical Center Goettingen, Goettingen, Germany; Research Group Translational Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Goettingen, Germany.
Michael W SeredaDepartment of Neurology, University Medical Center Goettingen, Goettingen, Germany; Research Group Translational Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Goettingen, Germany. Electronic address: sereda@mpinat.mpg.de.
Max Planck Institute of Experimental Medicine · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hexokinase (HK)-1 mitochondrial-binding mechanisms and consequential physiological relevance remain unclear. Recently, De Jesus et al. studied myeloid cells with HK1 carrying mutated mitochondrial-binding domains (MBDs) and provided evidence that HK1 localization controls glucose metabolic fate. Increases in cytosolic HK1 may also contribute to the inflammation associated with diabetes and aging.

Indexed as

HexokinaseMitochondriaCarbohydrate MetabolismGlucoseHumansInflammationGlucoseHexokinaseHK1 protein, humanagingdeacetylationdiabetesglucose metabolisminflammationnitrosylation

Identifiers

PMID35953432
OpenAlexW4290721375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.